Redcliffe Labs adds ‘Novaseq 6000’ sequencing system to its diagnostic technology portfolio
Makes it the first in North India to house the most sophisticated sequencing system useful in the diagnosis of rare conditions in newborns, infants and in pre-natal settings
Redcliffe Labs has announced the addition of ‘NovaSeq 6000’ sequencing system to their diagnostic technology portfolio at its Noida National Reference Lab. With this, Redcliffe becomes the first in North India and among few in line in the country to line up the most advance and high-end set of instruments, a company statement said.
While the system is being installed in the national lab, it serves the entire country with the most
efficient logistics and will reduce the testing time and help save costs for the patients in the neighbouring region and states.
Ease of access to NovaSeq 6000 sequencing system will prove to be useful, as, currently, there is no mass-level testing protocol rolled out by the states for genetic diseases.
Following the successful adoption of NovaSeq 6000 technology, high throughput speed and flexibility will be available to conduct research or tests that need the processing of massive amounts of data in a more efficient and cost-effective manner.
- Advertisement -